Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase

References

• Nussbaum C, Klinke A, Adam M, Baldus S, Sperandio M. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid Redox Signal 2013;18:692–713.
   PubMed Web of Science ®Google Scholar
• van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 1997;327:487–492.
   PubMed Web of Science ®Google Scholar
• van Dalen CJ, Winterbourn CC, Senthilmohan R, Kettle AJ. Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J Biol Chem 2000;275:11638–11644.
   Google Scholar
• Choi DK, Koppula S, Choi M, Suk K. Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target. Expert Opin Ther Pat 2010;20:1531–1546.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Hawkins CL, Pattison DI, Rees MD. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:1199–1234.
   PubMed Web of Science ®Google Scholar
• Malle E, Furtmuller PG, Sattler W, Obinger C. Myeloperoxidase: a target for new drug development? Br J Pharmacol 2007;152:838–854.
   PubMed Web of Science ®Google Scholar
• Skaff O, Pattison DI, Davies MJ. Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: Absolute rate constants and assessment of biological relevance. Biochem J 2009;422:111–117.
   PubMed Web of Science ®Google Scholar
• Nagy P, Jameson GN, Winterbourn CC. Kinetics and mechanisms of the reaction of hypothiocyanous acid with 5-thio-2-nitrobenzoic acid and reduced glutathione. Chem Res Toxicol 2009;22:1833–1840.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Hawkins CL, Davies MJ. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol 2009;22:807–817.
   PubMed Web of Science ®Google Scholar
• Morgan PE, Pattison DI, Talib J, Summers FA, Harmer JA, Celermajer DS, et al. High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radic Biol Med 2011;51:1815–1822.
   PubMed Web of Science ®Google Scholar
• Talib J, Pattison DI, Harmer JA, Celermajer DS, Davies MJ. High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radic Biol Med 2012;53:20–29.
   PubMed Web of Science ®Google Scholar
• Ashby MT, Kreth J, Soundarajan M, Sivuilu LS. Influence of a model human defensive peroxidase system on oral streptococcal antagonism. Microbiology 2009;155:3691–3700.
   PubMed Web of Science ®Google Scholar
• Chandler JD, Min E, Huang J, Nichols DP, Day BJ. Nebulized thiocyanate improves lung infection outcomes in mice. Br J Pharmacol 2013;169:1166–1177.
   PubMed Web of Science ®Google Scholar
• Chandler JD, Day BJ. Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. Biochem Pharmacol 2012;84:1381–1387.
   PubMed Web of Science ®Google Scholar
• Nedoboy PE, Morgan PE, Mocatta TJ, Richards AM, Winterbourn CC, Davies MJ. High plasma thiocyanate levels are associated with enhanced myeloperoxidase-induced thiol oxidation and long-term survival in subjects following a first myocardial infarction. Free Radic Res 2014;48:1256–1266.
   PubMed Web of Science ®Google Scholar
• Hadfield KA, Pattison DI, Brown BE, Hou L, Rye KA, Davies MJ, Hawkins CL. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl). Biochem J 2013;449:531–542.
   PubMed Web of Science ®Google Scholar
• Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL. Free Radic Biol Med 2004;37: 146–155.
   PubMed Web of Science ®Google Scholar
• Barrett TJ, Pattison DI, Leonard SE, Carroll KS, Davies MJ, Hawkins CL. Inactivation of thiol-dependent enzymes by hypothiocyanous acid: role of sulfenyl thiocyanate and sulfenic acid intermediates. Free Radic Biol Med 2012;52: 1075–1085.
   PubMed Web of Science ®Google Scholar
• Cook NL, Pattison DI, Davies MJ. Myeloperoxidase-derived oxidants rapidly oxidize and disrupt zinc-cysteine/histidine clusters in proteins. Free Radic Biol Med 2012;53: 2072–2080.
   PubMed Web of Science ®Google Scholar
• Talib J, Kwan J, Suryo Rahmanto A, Witting PK, Davies MJ. The smoking-associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction. Biochem J 2014;457:89–97.
   PubMed Web of Science ®Google Scholar
• Hawkins CL. The role of hypothiocyanous acid (HOSCN) in biological systems. Free Radic Res 2009;43:1147–1158.
   PubMed Web of Science ®Google Scholar
• Castellani LW, Chang JJ, Wang X, Lusis AJ, Reynolds WF. Transgenic mice express human MPO -463 G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463 G males. J Lipid Res 2006;47:1366–1377.
   PubMed Web of Science ®Google Scholar
• McMillen TS, Heinecke JW, LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005;111:2798–2804.
   PubMed Web of Science ®Google Scholar
• Asselbergs FW, Tervaert JW, Tio RA. Prognostic value of myeloperoxidase in patients with chest pain. New Eng J Med 2004;350:516–518.
   PubMed Web of Science ®Google Scholar
• Tang N, Wang Y, Mei Q. Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis. Gene 2013;523:152–157.
   PubMed Web of Science ®Google Scholar
• Kumar AP, Piedrafita FJ, Reynolds WF. Peroxisome proliferator-activated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem 2004;279:8300–8315.
   PubMed Web of Science ®Google Scholar
• Mehrabian M, Qiao JH, Hyman R, Ruddle D, Laughton C, Lusis AJ. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb 1993;13:1–10.
   PubMedGoogle Scholar
• Hawkins CL, Morgan PE, Davies MJ. Quantification of protein modification by oxidants. Free Radic Biol Med 2009;46:965–988.
   PubMed Web of Science ®Google Scholar
• Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 1995;274:131–136.
   Google Scholar
• Nicholls SJ, Wilson Tang WH, Brennan D, Brennan ML, Mann S, Nissen SE, Hazen SL. Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain. Clin Chem 2011;57:1762–1770.
   PubMed Web of Science ®Google Scholar
• Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440–1445.
   PubMed Web of Science ®Google Scholar
• Rausch PG, Moore TG. Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison. Blood 1975;46: 913–919.
   PubMed Web of Science ®Google Scholar
• Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, et al. Increased atherosclerosis in myeloperoxidase- deficient mice. J Clin Invest 2001;107:419–430.
   PubMed Web of Science ®Google Scholar
• van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, Heeringa P, et al. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol 2008;28:84–89.
   PubMed Web of Science ®Google Scholar
• Olszowy HA, Rossiter J, Hegarty J, Geoghegan P. Background levels of bromide in human blood. J Anal Toxicol 1998;22: 225–230.
   PubMed Web of Science ®Google Scholar
• Haberland ME, Olch CL, Fogelman AM. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem 1984;259:11305–11311.
   PubMed Web of Science ®Google Scholar
• Hazell LJ, van den Berg JJ, Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem J 1994;302:297–304.
   PubMed Web of Science ®Google Scholar
• Shao B, Oda MN, Oram JF, Heinecke, JW. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. Chem Res Toxicol 2010;23:447–454.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining insight into human inflammatory diseases. Curr Med Chem 2006;13: 3271–3290.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ, Hawkins CL. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res 2012;46:975–995.
   PubMed Web of Science ®Google Scholar
• Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006;47:1005–1111.
   PubMed Web of Science ®Google Scholar
• Berndt C, Lillig CH, Holmgren A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol 2007;292:H1227–H1236.
   PubMed Web of Science ®Google Scholar